Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Design Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 63 | 1 | 74 | +12 |
| Shares | 38.0M | 3.87K | 38.7M | +703.8K (+1.9%) |
| Value | $613.7M | $63.0K | $541.7M | −$72.0M (−11.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Design Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 40,523 | $567.0K | 0.01% |
| Dimensional Fund Advisors LP | 28,144 | $394.0K | 0.00% |
| Allianz Asset Management GmbH | 26,696 | $374.0K | 0.00% |
| Susquehanna International Group, LLP | 23,904 | $335.0K | 0.00% |
| Alliancebernstein L.P. | 14,000 | $196.0K | 0.00% |
| Tudor Investment Corp Et Al | 12,900 | $181.0K | 0.01% |
| Jane Street Group, LLC | 12,705 | $178.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 12,630 | $177.0K | 0.00% |
| Voya Investment Management LLC | 12,572 | $176.0K | 0.00% |
| SG Americas Securities, LLC | 11,812 | $165.0K | 0.00% |
| Invesco Ltd. | 10,137 | $142.0K | 0.00% |
| Virtus ETF Advisers LLC | 7,716 | $108.0K | 0.04% |
| Fred Alger Management, LLC | 6,578 | $92.0K | 0.00% |
| Russell Investments Group, Ltd. | 2,344 | $32.0K | 0.00% |
| Captrust Financial Advisors | 143 | $2.00K | 0.00% |
| Howe & Rusling Inc | 44 | $1.00K | 0.00% |
| FourThought Financial, LLC | 44 | $1.00K | 0.00% |
| Credit Suisse AG | 31 | $0 | 0.00% |
| Rockefeller Capital Management L.P. | 61 | $0 | 0.00% |
Sold out (7)
Institutions that held Design Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Norges Bank | 200,000 | $3.23M |
| Ensign Peak Advisors, Inc | 50,000 | $808.0K |
| State of Wisconsin Investment Board | 35,600 | $575.0K |
| Qube Research & Technologies Ltd | 20,396 | $329.0K |
| ProShare Advisors LLC | 10,755 | $174.0K |
| Prospera Financial Services Inc | 1,404 | $23.0K |
| UBS Group AG | 998 | $16.0K |
Not filed for Q2 2022 yet (1)
Institutions that held Design Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 3,871 | $63.0K |